Author

С. В. Шалаев

Observed names: S SHALAEV, S V Shalaev, S. Shalaev, S. V Shalaev, S. V. SHalaev, S. V. Shalaev, S.V. Shalaev, S.V. Shalaev Shalaev, SV Shalaev, Sergei Shalaev, Sergei V. Shalaev, Sergei V. Shalaev Shalaev, Sergey Shalaev, Sergey V. Shalaev, SergeyVasilevich Shalaev, Shalaev S.V. Shalaev, О.В. Катышева

Institution: Tyumen State Medical University

Observed institutions: Turkmen State Medical University, Perm Regional Oncology Center, Institute of Oncology NN Petrov, Ministry of Health of the Russian Federation, Institute of Cardiology, Russian Society of Cardiology, Tyumen State Medical University

ORCID: 0000-0003-2724-4016

Observed ORCID: 0000-0003-2724-4016

OpenAlex ID: A5073715492

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

2019 · Kausik K Ray, Helen M Colhoun, et al. · The Lancet Diabetes & Endocrinology · 337

The Prevalence of Non-infectious Diseases Risk Factors in Russian Population in 2012-2013 Years. the Results of Ecvd-rf

2014 · G. A. Muromtseva, A. V. Kontsevaya, et al. · CARDIOVASCULAR THERAPY AND PREVENTION · 253

Arterial Hypertension Among Individuals of 25–64 Years Old: Prevalence, Awareness, Treatment and Control. by the Data From Eccd

2014 · S. A. Boytsov, Yu. A. Balanova, et al. · CARDIOVASCULAR THERAPY AND PREVENTION · 242

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

2019 · Deepak L Bhatt, Philippe Gabriel Steg, et al. · The Lancet · 212

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

2021 · Gregory G. Schwartz, Michael Szarek, et al. · Journal of the American College of Cardiology · 161

2024 Clinical practice guidelines for Stable coronary artery disease

2024 · O. L. Barbarash, Yu. A. Karpov, et al. · Russian Journal of Cardiology · 156

2020 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation

2021 · O. L. Barbarash, D. V. Duplyakov, et al. · Russian Journal of Cardiology · 147

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

2022 · Emil Hagström, P. Gabriel Steg, et al. · Circulation · 123

2024 Clinical practice guidelines for Acute myocardial infarction with ST segment elevation electrocardiogram

2025 · O. V. Averkov, G. K. Harutyunyan, et al. · Russian Journal of Cardiology · 87

Eurasian Clinical Guidelines on Diagnosis and Treatment of Pulmonary Hypertension

2020 · I. E. Chazova, T. V. Martynyuk, et al. · Eurasian heart journal · 77

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

2017 · Muthiah Vaduganathan, Robert A. Harrington, et al. · Journal of the American College of Cardiology · 59

2020 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension

2021 · S. N. Avdeev, O. L. Barbarash, et al. · Russian Journal of Cardiology · 58

Acute Kidney Injury after Transcatheter Aortic Valve Implantation

2022 · L. V. Kremneva, L. I. Gapon, et al. · Rational Pharmacotherapy in Cardiology · 50

Eurasian Association of Cardiology (eac) Guidelines for the Diagnosis and Treatment of Chronic Thromboembolic Pulmonary Hypertension (2020)

2021 · I. E. Chazova, T. V. Martynyuk, et al. · Eurasian heart journal · 50

Persistent dyslipidemia in statin-treated patients: Russian real-world clinical practice data (Russian part of the DYSIS Study)

2012 · R. G. Oganov, V. V. Kukharchuk, et al. · CARDIOVASCULAR THERAPY AND PREVENTION · 46

Awareness and Treatment Specifics of Statin Therapy in Persons With Various Cardiovasular Risk: the Study Esse-rf

2016 · S. A. Shalnova, A. D. Deev, et al. · CARDIOVASCULAR THERAPY AND PREVENTION · 41

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

2021 · Gregory G. Schwartz, Michael Szarek, et al. · Diabetes Care · 40

Acute kidney injury in patients with ST-segment elevation acute myocardial infarction: Predictors and outcomes

2021 · EvgenyMikhailovich Mezhonov, IuliiaAleksandrovna Vialkina, et al. · Saudi Journal of Kidney Diseases and Transplantation · 14

Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX

2021 · Matthew A. Cavender, Robert A. Harrington, et al. · Circulation Cardiovascular Interventions · 8

The Specifics of Hypertension Prevalence in Tyumenskaya Region and Its Treatment Efficacy Among Inhabitants of 25-64 Year Old

2017 · A. Yu. Efanov, M. A. Storojok, et al. · CARDIOVASCULAR THERAPY AND PREVENTION · 6

Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension associated with congenital heart defects in adults (2021)

2022 · I. E. Chazova, S. V. Gorbachevskij, et al. · Eurasian heart journal · 5

TREATMENT ADHERENCE AND EFFICACY OF ANTIHYPERTENSION TREATMENT IN HYPERTENSIVES IN TYUMENSKAYA ObLAST

2018 · A. Yu. Efanov, I. M. Petrov, et al. · Russian Journal of Cardiology · 5

The Role of Modern Technologies in Dispensary Follow-up of Arterial Hypertension Patients in Tyumen Region, Included Into the Chronic Non-communicable Disease Registry

2017 · A. Yu. Efanov, L. V. Kremneva, et al. · CARDIOVASCULAR THERAPY AND PREVENTION · 5

Prevalence of Cardiovascular Risk Factors in Non-organized Population of 25-64 Year Olds in Tyumen Region. Results of Esse-rf Study in Tyumen Region

2016 · A. Yu. Efanov, М. A. Storozhok, et al. · CARDIOVASCULAR THERAPY AND PREVENTION · 4

Evolution of Thrombolytic Therapy in the Treatment of Myocardial Infarction

2014 · P. G. Kesov, O. M. Reytblat, et al. · Rational Pharmacotherapy in Cardiology · 4

Works count: 136

Citation count: 2,306

H-index: 18

I10-index: 19